Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera

NCT01949805 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

257

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycythemia Vera

Interventions

DRUG: Peg-P-IFN-alpha-2b (AOP2014)
DRUG: Hydroxyurea

Sponsor

AOP Orphan Pharmaceuticals AG

Collaborators

[object Object]